Literature DB >> 27990047

Long-term prescribing of new oral anticoagulants.

Paul Kl Chin1, Matthew P Doogue2.   

Abstract

Keywords:  anticoagulant; apixaban; atrial fibrillation; bleeding; dabigatran; rivaroxaban; stroke; thromboembolism; warfarin

Year:  2016        PMID： 27990047      PMCID： PMC5155059          DOI： 10.18773/austprescr.2016.068

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  22 in total

1.  Risk of bleeding with dabigatran in atrial fibrillation.

Authors:  Inmaculada Hernandez; Seo Hyon Baik; Antonio Piñera; Yuting Zhang
Journal:  JAMA Intern Med       Date:  2015-01       Impact factor: 21.873

Review 2.  Idarucizumab.

Authors: 
Journal:  Aust Prescr       Date:  2016-10-01

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

Authors:  Paul A Reilly; Thorsten Lehr; Sebastian Haertter; Stuart J Connolly; Salim Yusuf; John W Eikelboom; Michael D Ezekowitz; Gerhard Nehmiz; Susan Wang; Lars Wallentin
Journal:  J Am Coll Cardiol       Date:  2013-09-27       Impact factor: 24.094

Review 5.  Which patients may benefit from dose adjustment of non-vitamin K antagonist oral anticoagulants?

Authors:  Paul K L Chin
Journal:  Semin Thromb Hemost       Date:  2015-02-17       Impact factor: 4.180

6.  The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.

Authors:  Stuart J Connolly; Lars Wallentin; Michael D Ezekowitz; John Eikelboom; Jonas Oldgren; Paul A Reilly; Martina Brueckmann; Janice Pogue; Marco Alings; John V Amerena; Alvaro Avezum; Iris Baumgartner; Andrzej J Budaj; Jyh-Hong Chen; Antonio L Dans; Harald Darius; Giuseppe Di Pasquale; Jorge Ferreira; Greg C Flaker; Marcus D Flather; Maria Grazia Franzosi; Sergey P Golitsyn; David A Halon; Hein Heidbuchel; Stefan H Hohnloser; Kurt Huber; Petr Jansky; Gabriel Kamensky; Matyas Keltai; Sung Soon Kim; Chu-Pak Lau; Jean-Yves Le Heuzey; Basil S Lewis; Lisheng Liu; John Nanas; Razali Omar; Prem Pais; Knud E Pedersen; Leopoldo S Piegas; Dimitar Raev; Pal J Smith; Mario Talajic; Ru San Tan; Supachai Tanomsup; Lauri Toivonen; Dragos Vinereanu; Denis Xavier; Jun Zhu; Susan Q Wang; Christine O Duffy; Ellison Themeles; Salim Yusuf
Journal:  Circulation       Date:  2013-06-14       Impact factor: 29.690

7.  Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration.

Authors:  Supriya Shore; Evan P Carey; Mintu P Turakhia; Cynthia A Jackevicius; Fran Cunningham; Louise Pilote; Steven M Bradley; Thomas M Maddox; Gary K Grunwald; Anna E Barón; John S Rumsfeld; Paul D Varosy; Preston M Schneider; Lucas N Marzec; P Michael Ho
Journal:  Am Heart J       Date:  2014-04-05       Impact factor: 4.749

8.  New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.

Authors:  H Tran; J Joseph; L Young; S McRae; J Curnow; H Nandurkar; P Wood; C McLintock
Journal:  Intern Med J       Date:  2014-06       Impact factor: 2.048

Review 9.  Antidotes for novel oral anticoagulants: current status and future potential.

Authors:  Mark Crowther; Mark A Crowther
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-18       Impact factor: 8.311

Review 10.  How to manage warfarin therapy.

Authors:  Philip A Tideman; Rosy Tirimacco; Andrew St John; Gregory W Roberts
Journal:  Aust Prescr       Date:  2015-04-01
View more
  6 in total

1.  Pharmacokinetics of apixaban.

Authors:  Penny Beirne
Journal:  Aust Prescr       Date:  2017-06-01

2.  Treating patients on new anticoagulant drugs.

Authors:  Shyan Goh
Journal:  Aust Prescr       Date:  2017-04-03

Review 3.  Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants.

Authors:  Scott Kaatz; Charles E Mahan; Asaad Nakhle; Kulothungan Gunasekaran; Mahmoud Ali; Robert Lavender; David G Paje
Journal:  Curr Cardiol Rep       Date:  2017-10-24       Impact factor: 2.931

4.  Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies.

Authors:  Shahrzad Salmasi; Peter S Loewen; Rachel Tandun; Jason G Andrade; Mary A De Vera
Journal:  BMJ Open       Date:  2020-04-08       Impact factor: 2.692

5.  Precision dosing to avoid adverse drug reactions.

Authors:  Thomas M Polasek; Carl M J Kirkpatrick; Amin Rostami-Hodjegan
Journal:  Ther Adv Drug Saf       Date:  2019-12-11

Review 6.  A Review of the Incidence Diagnosis and Treatment of Spontaneous Hemorrhage in Patients Treated with Direct Oral Anticoagulants.

Authors:  Kulothungan Gunasekaran; Venkat Rajasurya; Joe Devasahayam; Mandeep Singh Rahi; Arul Chandran; Kalaimani Elango; Goutham Talari
Journal:  J Clin Med       Date:  2020-09-15       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.